Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care
Launched by ANNE-SOPHIE BRAZEAU · Jun 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how an online training and peer support platform, called Support-t, can help teenagers with Type 1 Diabetes (T1D) prepare for the transition to adult healthcare. The study involves 14-16 year-olds who are receiving diabetes care at specific pediatric diabetes clinics in Quebec. Researchers want to see if using this online program, along with their usual care, can lead to better health outcomes, like improved blood sugar control and overall well-being, compared to just receiving usual care alone.
To participate in this study, young people need to be diagnosed with Type 1 Diabetes, be between 14 and 16 years old, have internet access, and be fluent in either English or French. They will be asked to engage with the online platform and attend regular follow-up appointments. It's important to note that those with severe cognitive disabilities or certain blood conditions that affect test results won't be eligible. Participants will have the chance to learn more about managing their diabetes while also connecting with peers who are going through similar experiences.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adolescents with a clinical diagnosis of T1D
- • 14-16 years of age
- • Receiving diabetes care at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill University Health Centre, Centre hospitalier universitaire de Sherbrooke, Le Copain-Hôpital de Gatineau, Centre Hospitalier Universitaire de Québec
- • Having access to internet
- • Having an active email address
- • Fluent in English or French
- Exclusion Criteria:
- • Severe neurocognitive disabilities
- • Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c
About Anne Sophie Brazeau
Anne-Sophie Brazeau is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the healthcare sector, she focuses on innovative therapeutic solutions and the efficient management of clinical trials. Her leadership emphasizes ethical practices, regulatory compliance, and collaboration with multidisciplinary teams to ensure high-quality research standards. Through her initiatives, Brazeau aims to foster a dynamic environment that accelerates the development of groundbreaking treatments, ultimately contributing to the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sherbrooke, , Canada
Québec, , Canada
Gatineau, , Canada
Montréal, , Canada
Patients applied
Trial Officials
Anne-Sophie Brazeau, PhD
Principal Investigator
School of Human Nutrition - McGill University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported